News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neuron to Publish PRANA Biotechnology (PRAN)'s PBT2 Preclinical Research


7/9/2008 12:34:13 PM

MELBOURNE, AUSTRALIA--(Marketwire - July 09, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT) today announced the publication of key research findings with its lead Alzheimer's Disease drug, PBT2. The article titled "Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxyquinoline analogs is associated with decreased interstitial Abeta" appears in the current edition of the prestigious scientific journal Neuron, and can be viewed online.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES